URL:

Share this on AAFP Connection

This was successfully posted to your pofile.
This box will close automatically in a few seconds. Close this window

Share this on AAFP Connection

We don't have an e-mail address on file for you. To use AAFP Connection, you must have an e-mail address in our records. Click Here

Share this on AAFP Connection

You have logged in, however...

You do not have access to the AAFP members-only section. AAFP Connection is a members-only social network. Only members of the American Academy of Family Physicians can view AAFP Connection profiles.

Are you a member but don't have access? Contact us.

Interested in becoming a member? Learn more about AAFP membership and its benefits.

Share this page

Hepatitis C

AAFP CME Bulletin

Important drug safety information about telaprevir for readers of the print version of this CME Bulletin.

Read now.

or download the CME Bulletin as a PDF file (6-page PDF; About PDFs)

After reading this CME Bulletin, you should be able to:

Evaluate techniques for initiating dialogue with patients to determine their risk of hepatitis C virus (HCV) infection.
Determine the confounding factors that influence the treatment of patients with hepatitis C.
Evaluate the value of national/local community resources to improve the treatment of patients with hepatitis C.

After reading the CME Bulletin, login to complete the quiz and evaluation. (Members only).

Hepatitis C

More AAFP CME Bulletins

Important Drug Safety Information

AAFP ID
Password
	Remember Me